These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16260183)

  • 1. Clinical link between MHC class II haplotype and interferon-beta (IFN-beta) immunogenicity.
    Barbosa MD; Vielmetter J; Chu S; Smith DD; Jacinto J
    Clin Immunol; 2006 Jan; 118(1):42-50. PubMed ID: 16260183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta.
    Stickler M; Valdes AM; Gebel W; Razo OJ; Faravashi N; Chin R; Rochanayon N; Harding FA
    Genes Immun; 2004 Jan; 5(1):1-7. PubMed ID: 14735143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosis.
    Garg N; Weinstock-Guttman B; Bhasi K; Locke J; Ramanathan M
    Mult Scler; 2007 Aug; 13(7):895-9. PubMed ID: 17468449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between certain major histocompatibility complex class II and T-cell receptor V beta alleles promotes the antibody production to extractable nuclear antigen-related peptides.
    Youinou P; Semana G; Muller S; Piette JC; Guillevin L; Jouquan J; Salmon D; Salmon J; Genetet B; Bach JF
    Hum Immunol; 1997 Jan; 52(1):12-21. PubMed ID: 9021405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
    Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo.
    Perini P; Facchinetti A; Bulian P; Massaro AR; Pascalis DD; Bertolotto A; Biasi G; Gallo P
    Eur Cytokine Netw; 2001 Mar; 12(1):56-61. PubMed ID: 11282547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
    Zota V; Nemirovsky A; Baron R; Fisher Y; Selkoe DJ; Altmann DM; Weiner HL; Monsonego A
    J Immunol; 2009 Sep; 183(5):3522-30. PubMed ID: 19675171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel assay to detect low-titred antibodies to interferon beta in multiple sclerosis patients.
    Di Marco P; Pagnotti P; Bellomi F; De Vito G; Sessa E; Bagnato F; Scagnolari C; Bramanti P; Antonelli G
    New Microbiol; 2006 Jan; 29(1):11-8. PubMed ID: 16608120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta inhibits Th1 responses at the dendritic cell level. Relevance to multiple sclerosis.
    Bartholomé EJ; Willems F; Crusiaux A; Thielemans K; Schandené L; Goldman M
    Acta Neurol Belg; 1999 Mar; 99(1):44-52. PubMed ID: 10218092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain.
    Merryman P; Silver J; Gregersen PK; Solomon G; Winchester R
    J Immunol; 1989 Sep; 143(6):2068-73. PubMed ID: 2476494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.
    Endl J; Otto H; Jung G; Dreisbusch B; Donie F; Stahl P; Elbracht R; Schmitz G; Meinl E; Hummel M; Ziegler AG; Wank R; Schendel DJ
    J Clin Invest; 1997 May; 99(10):2405-15. PubMed ID: 9153283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J; Minato N; Kano S
    J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.